The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Viral Molecular Diagnostics Market Research Report 2025
Synopsis
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global Viral Molecular Diagnostics market was valued at US$ 8000 million in 2023 and is anticipated to reach US$ 13090 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Viral Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Molecular Diagnostics.
Report Scope
The Viral Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboraories
Bio-Rad Laboratories
Becton, Dickinson
Roche
Gen-Probe
Qiagen
Olympus
Thermo Fisher Scientific
Segment by Type
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)
Segment by Application
Hospitals
Academics Institutions
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Molecular diagnostics refers to a technique used to detect and identify the presence of genetic material or proteins associated with a specific health condition or disease.
The global Viral Molecular Diagnostics market was valued at US$ 8000 million in 2023 and is anticipated to reach US$ 13090 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Viral Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Molecular Diagnostics.
Report Scope
The Viral Molecular Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Molecular Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboraories
Bio-Rad Laboratories
Becton, Dickinson
Roche
Gen-Probe
Qiagen
Olympus
Thermo Fisher Scientific
Segment by Type
Hepatitis B Virus (HBV)
Hepatitis C Virus (HCV)
Human Immunodeficiency Virus (HIV)
Human Papillomavirus (HPV)
Segment by Application
Hospitals
Academics Institutions
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Molecular Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Molecular Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hepatitis B Virus (HBV)
1.2.3 Hepatitis C Virus (HCV)
1.2.4 Human Immunodeficiency Virus (HIV)
1.2.5 Human Papillomavirus (HPV)
1.3 Market by Application
1.3.1 Global Viral Molecular Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Academics Institutions
1.3.4 Laboratories
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Molecular Diagnostics Market Perspective (2019-2030)
2.2 Viral Molecular Diagnostics Growth Trends by Region
2.2.1 Global Viral Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Molecular Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Viral Molecular Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Viral Molecular Diagnostics Market Dynamics
2.3.1 Viral Molecular Diagnostics Industry Trends
2.3.2 Viral Molecular Diagnostics Market Drivers
2.3.3 Viral Molecular Diagnostics Market Challenges
2.3.4 Viral Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Molecular Diagnostics Players by Revenue
3.1.1 Global Top Viral Molecular Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Viral Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Viral Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Molecular Diagnostics Revenue
3.4 Global Viral Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Viral Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Molecular Diagnostics Revenue in 2023
3.5 Viral Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Viral Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Viral Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Molecular Diagnostics Breakdown Data by Type
4.1 Global Viral Molecular Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Viral Molecular Diagnostics Forecasted Market Size by Type (2025-2030)
5 Viral Molecular Diagnostics Breakdown Data by Application
5.1 Global Viral Molecular Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Viral Molecular Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Molecular Diagnostics Market Size (2019-2030)
6.2 North America Viral Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Molecular Diagnostics Market Size by Country (2019-2024)
6.4 North America Viral Molecular Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Molecular Diagnostics Market Size (2019-2030)
7.2 Europe Viral Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Molecular Diagnostics Market Size by Country (2019-2024)
7.4 Europe Viral Molecular Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Molecular Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Viral Molecular Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Molecular Diagnostics Market Size (2019-2030)
9.2 Latin America Viral Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Molecular Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Viral Molecular Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Molecular Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Viral Molecular Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboraories
11.1.1 Abbott Laboraories Company Detail
11.1.2 Abbott Laboraories Business Overview
11.1.3 Abbott Laboraories Viral Molecular Diagnostics Introduction
11.1.4 Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.1.5 Abbott Laboraories Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Viral Molecular Diagnostics Introduction
11.2.4 Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Detail
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson Viral Molecular Diagnostics Introduction
11.3.4 Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.3.5 Becton, Dickinson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Viral Molecular Diagnostics Introduction
11.4.4 Roche Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Gen-Probe
11.5.1 Gen-Probe Company Detail
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe Viral Molecular Diagnostics Introduction
11.5.4 Gen-Probe Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.5.5 Gen-Probe Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Detail
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Viral Molecular Diagnostics Introduction
11.6.4 Qiagen Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.6.5 Qiagen Recent Development
11.7 Olympus
11.7.1 Olympus Company Detail
11.7.2 Olympus Business Overview
11.7.3 Olympus Viral Molecular Diagnostics Introduction
11.7.4 Olympus Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.7.5 Olympus Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Detail
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Viral Molecular Diagnostics Introduction
11.8.4 Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2019-2024)
11.8.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Viral Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hepatitis B Virus (HBV)
Table 3. Key Players of Hepatitis C Virus (HCV)
Table 4. Key Players of Human Immunodeficiency Virus (HIV)
Table 5. Key Players of Human Papillomavirus (HPV)
Table 6. Global Viral Molecular Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Viral Molecular Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Viral Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Viral Molecular Diagnostics Market Share by Region (2019-2024)
Table 10. Global Viral Molecular Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Viral Molecular Diagnostics Market Share by Region (2025-2030)
Table 12. Viral Molecular Diagnostics Market Trends
Table 13. Viral Molecular Diagnostics Market Drivers
Table 14. Viral Molecular Diagnostics Market Challenges
Table 15. Viral Molecular Diagnostics Market Restraints
Table 16. Global Viral Molecular Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Viral Molecular Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2023)
Table 19. Ranking of Global Top Viral Molecular Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Viral Molecular Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Viral Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Viral Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Viral Molecular Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Viral Molecular Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global Viral Molecular Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Viral Molecular Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global Viral Molecular Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Viral Molecular Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global Viral Molecular Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Viral Molecular Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Viral Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Viral Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Viral Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Viral Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Viral Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Viral Molecular Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Viral Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Viral Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Viral Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Viral Molecular Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Laboraories Company Detail
Table 49. Abbott Laboraories Business Overview
Table 50. Abbott Laboraories Viral Molecular Diagnostics Product
Table 51. Abbott Laboraories Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 52. Abbott Laboraories Recent Development
Table 53. Bio-Rad Laboratories Company Detail
Table 54. Bio-Rad Laboratories Business Overview
Table 55. Bio-Rad Laboratories Viral Molecular Diagnostics Product
Table 56. Bio-Rad Laboratories Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Bio-Rad Laboratories Recent Development
Table 58. Becton, Dickinson Company Detail
Table 59. Becton, Dickinson Business Overview
Table 60. Becton, Dickinson Viral Molecular Diagnostics Product
Table 61. Becton, Dickinson Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Becton, Dickinson Recent Development
Table 63. Roche Company Detail
Table 64. Roche Business Overview
Table 65. Roche Viral Molecular Diagnostics Product
Table 66. Roche Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Gen-Probe Company Detail
Table 69. Gen-Probe Business Overview
Table 70. Gen-Probe Viral Molecular Diagnostics Product
Table 71. Gen-Probe Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Gen-Probe Recent Development
Table 73. Qiagen Company Detail
Table 74. Qiagen Business Overview
Table 75. Qiagen Viral Molecular Diagnostics Product
Table 76. Qiagen Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 77. Qiagen Recent Development
Table 78. Olympus Company Detail
Table 79. Olympus Business Overview
Table 80. Olympus Viral Molecular Diagnostics Product
Table 81. Olympus Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 82. Olympus Recent Development
Table 83. Thermo Fisher Scientific Company Detail
Table 84. Thermo Fisher Scientific Business Overview
Table 85. Thermo Fisher Scientific Viral Molecular Diagnostics Product
Table 86. Thermo Fisher Scientific Revenue in Viral Molecular Diagnostics Business (2019-2024) & (US$ Million)
Table 87. Thermo Fisher Scientific Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Molecular Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Molecular Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Hepatitis B Virus (HBV) Features
Figure 4. Hepatitis C Virus (HCV) Features
Figure 5. Human Immunodeficiency Virus (HIV) Features
Figure 6. Human Papillomavirus (HPV) Features
Figure 7. Global Viral Molecular Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Viral Molecular Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Academics Institutions Case Studies
Figure 11. Laboratories Case Studies
Figure 12. Others Case Studies
Figure 13. Viral Molecular Diagnostics Report Years Considered
Figure 14. Global Viral Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Viral Molecular Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Viral Molecular Diagnostics Market Share by Region: 2023 VS 2030
Figure 17. Global Viral Molecular Diagnostics Market Share by Players in 2023
Figure 18. Global Top Viral Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Molecular Diagnostics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Viral Molecular Diagnostics Revenue in 2023
Figure 20. North America Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Viral Molecular Diagnostics Market Share by Country (2019-2030)
Figure 22. United States Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Viral Molecular Diagnostics Market Share by Country (2019-2030)
Figure 26. Germany Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Viral Molecular Diagnostics Market Share by Region (2019-2030)
Figure 34. China Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Viral Molecular Diagnostics Market Share by Country (2019-2030)
Figure 42. Mexico Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Viral Molecular Diagnostics Market Share by Country (2019-2030)
Figure 46. Turkey Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Viral Molecular Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Laboraories Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 49. Bio-Rad Laboratories Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 50. Becton, Dickinson Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 52. Gen-Probe Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 53. Qiagen Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 54. Olympus Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Viral Molecular Diagnostics Business (2019-2024)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
